Zur Kurzanzeige

2014-02-01Zeitschriftenartikel DOI: 10.4161/hv.26986
Vaccination coverage among children in Germany estimated by analysis of health insurance claims data
dc.contributor.authorRieck, Thorsten
dc.contributor.authorFeig, Marcel
dc.contributor.authorEckmanns, Tim
dc.contributor.authorBenzler, Justus
dc.contributor.authorSiedler, Anette
dc.contributor.authorWichmann, Ole
dc.date.accessioned2018-05-07T17:30:16Z
dc.date.available2018-05-07T17:30:16Z
dc.date.created2014-02-19
dc.date.issued2014-02-01none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/reZa0I8XcUHj/PDF/25TOkz9Qm5nw.pdf
dc.identifier.urihttp://edoc.rki.de/176904/1823
dc.description.abstractIn Germany, the national routine childhood immunization schedule comprises 12 vaccinations. Primary immunizations should be completed by 24 mo of age. However, nationwide monitoring of vaccination coverage (VC) is performed only at school entry. We utilized health insurance claims data covering ~85% of the total population with the objectives to (1) assess VC of all recommended childhood vaccinations in birth-cohorts 2004–2009, (2) analyze cross-sectional (at 24 and 36 mo) and longitudinal trends, and (3) validate the method internally and externally. Counting vaccine doses in a retrospective cohort fashion, we assembled individual vaccination histories and summarized VC to nationwide figures. For most long-established vaccinations, VC at 24 mo was at moderate levels (~73–80%) and increased slightly across birth-cohorts. One dose measles VC was high (94%), but low (69%) for the second dose. VC with a full course of recently introduced varicella, pneumococcal, and meningococcal C vaccines increased across birth-cohorts from below 10% above 60%, 70%, and 80%, respectively. At 36 mo, VC had increased further by up to 15 percentage points depending on vaccination. Longitudinal analysis suggested a continued VC increase until school entry. Validation of VC figures with primary data showed an overall good agreement. In conclusion, analysis of health insurance claims data allows for the estimation of VC among children in Germany considering completeness and timeliness of vaccination series. This approach provides valid nationwide VC figures for all currently recommended pediatric vaccinations and fills the information gap between early infancy and late assessment at school entry.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionsepidemiologie
dc.subject.ddc610 Medizin
dc.titleVaccination coverage among children in Germany estimated by analysis of health insurance claims data
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10035226
dc.identifier.doi10.4161/hv.26986
dc.identifier.doihttp://dx.doi.org/10.25646/1748
local.edoc.container-titleHuman Vaccines & Immunotherapeutics
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.landesbioscience.com/journals/vaccines/article/26986/
local.edoc.container-publisher-nameLandes Bioscience
local.edoc.container-volume10
local.edoc.container-issue2
local.edoc.container-year2014

Zur Kurzanzeige